albendazole has been researched along with valganciclovir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bird, D; Francis, JM; Gautam, A; Ingalls, R; Kabbani, D; Kwah, J; Nuhn, M; Roseman, DA | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
2 review(s) available for albendazole and valganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
1 other study(ies) available for albendazole and valganciclovir
| Article | Year |
|---|---|
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor.
Topics: Adult; Albendazole; Animals; Ganciclovir; Humans; Immunocompromised Host; Ivermectin; Kidney Transplantation; Malabsorption Syndromes; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Tissue Donors; Transplantation, Homologous; Valganciclovir | 2013 |